title: Allogeneic bone marrow transplantation with total body irradiation-based conditioning in acute lymphoblastic leukemia patient with Cochlear implant.
abstract: OBJECTIVE
  A case of 15 years old boy with acute lymphoblastic leukemia and cochlear implant is presented.
  
  
  METHODS
  Allogeneic bone marrow transplantation with total body irradiation-based conditioning was performed.
  
  
  RESULTS
  No impairment of implant function nor other complications were observed. The patient is doing well over 20 months following bone marrow transplantation.
  
  
  CONCLUSIONS
  Total body irradiation can be used in conditioning before bone marrow transplantation in patients with cochlear implants.
authors.affiliation: Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland. mir.markiewicz@wp.pl
authors.forename: Mirosław
authors.initials: M
authors.lastname: Markiewicz
authors.forename: Sebastian
authors.initials: S
authors.lastname: Giebel
authors.forename: Iwona
authors.initials: I
authors.lastname: Wyleioł
authors.forename: Renata
authors.initials: R
authors.lastname: Tomaszewska
authors.forename: Leszek
authors.initials: L
authors.lastname: Miszczyk
authors.forename: Grazyna
authors.initials: G
authors.lastname: Gawlicka
authors.forename: Jerzy
authors.initials: J
authors.lastname: Wojnar
authors.forename: Jerzy
authors.initials: J
authors.lastname: Holowiecki
mesh_terms: D000293:Adolescent; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D019929:Cochlear Implantation; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D013997:Time Factors; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D014916:Whole-Body Irradiation / Q000009:adverse effects / Q000379:methods*
chemical_list: D000964:Antimetabolites, Antineoplastic; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008727:Methotrexate